Mon, Feb 23, 2026
Effective May 1, 2026, 115 codes will be added to the prior authorization list related to medical and radiation oncology. This includes medications such as fluorouracil 500 mg, zoledronic acid injection 1 mg, and cisplatin injection 10 mg (see the full list in the table below). Authorization requests for these new codes will be reviewed by Evolent as part of Highmark’s oncology value-based care strategy.
All authorizations should be requested electronically through Availity Essentials. EviCore will continue to manage radiation oncology authorization requests for our Administrative Services Only (ASO) members, and Highmark will route authorization requests to Evolent or EviCore as appropriate once they are received through Availity.
Code |
Description |
77436 |
SURFACE RADIATION THERAPY; SUPERFICIAL OR ORTHOVOLTAGE, TREATMENT PLANNING AND SIMULATION-AIDED FIELD SETTING |
77437 |
SURFACE RADIATION THERAPY; SUPERFICIAL, DELIVERY, </=150 kV, PER FRACTION (e.g., ELECTRONIC BRACHYTHERAPY) |
77438 |
SURFACE RADIATION THERAPY; ORTHOVOLTAGE, DELIVERY, >150-500 kV, PER FRACTION |
77011 |
COMPUTED TOMOGRAPHY GUIDANCE FOR STEREOTACTIC LOCALIZATION |
A9600 |
STRONTIUM SR-89 CHLORIDE, THERAPEUTIC, PER MILLICURIE |
A9604 |
SAMARIUM SM-153 LEXIDRONAM, THERAPEUTIC, PER TREATMENT DOSE, UP TO 150 MILLICURIES |
C9047 |
INJECTION, CAPLACIZUMAB-YHDP, 1 MG |
C9293 |
INJECTION, GLUCARPIDASE, 10 UNITS |
J0185 |
INJECTION, APREPITANT, 1 MG |
J0207 |
INJECTION, AMIFOSTINE, 500 MG |
J0208 |
INJECTION, SODIUM THIOSULFATE (PEDMARK), 100 MG |
J0641 |
INJECTION, LEVOLEUCOVORIN, NOT OTHERWISE SPECIFIED, 0.5 MG |
J0642 |
INJECTION, LEVOLEUCOVORIN (KHAPZORY), 0.5 MG |
J0870 |
INJECTION, IMETELSTAT, 1 MG |
J0881 |
INJECTION, DARBEPOETIN ALFA, 1 MICROGRAM (NON-ESRD USE) |
J0885 |
INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS |
J0888 |
INJECTION, EPOETIN BETA, 1 MCG, (FOR NON-ESRD USE) |
J0893 |
INJECTION, DECITABINE (SUN PHARMA) NOT THERAPEUTICALLY EQUIVALENT TO J0894, 1 MG |
J0894 |
INJECTION, DECITABINE, 1 MG |
J1190 |
INJECTION, DEXRAZOXANE HYDROCHLORIDE, PER 250 MG |
J1437 |
INJECTION, FERRIC DERISOMALTOSE, 10 MG |
J1439 |
INJECTION, FERRIC CARBOXYMALTOSE, 1MG |
J1454 |
INJECTION, FOSNETUPITANT 235 MG AND PALONOSETRON 0.25 MG |
J1627 |
INJECTION, GRANISETRON, EXTENDED-RELEASE, 0.1 MG |
J2277 |
INJECTION, MOTIXAFORTIDE, 0.25 MG |
J2354 |
INJECTION, OCTREOTIDE, NONDEPOT FORM FOR SUBCUTANEOUS OR INTRAVENOUS INJECTION, 25 MCG |
J2430 |
INJECTION, PAMIDRONATE DISODIUM, PER 30 MG |
J2562 |
INJECTION, PLERIXAFOR, 1 MG |
J2783 |
INJECTION, RASBURICASE, 0.5 MG |
J2802 |
INJECTION, ROMIPLOSTIM, 1 MICROGRAM |
J2916 |
INJECTION, SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE INJECTION, 12.5 MG |
J3489 |
INJECTION, ZOLEDRONIC ACID, 1 MG |
J9000 |
DOXORUBICIN HCL, 10 MG |
J9015 |
INJECTION, ALDESLEUKIN, PER SINGLE USE VIAL |
J9017 |
ARSENIC TRIOXIDE, 1MG |
J9025 |
INJECTION, AZACITIDINE, 1 MG |
J9027 |
INJECTION, CLOFARABINE, 1 MG |
J9030 |
BCG LIVE INTRAVESICAL INSTILLATION, 1 MG |
J9040 |
INJECTION, BLEOMYCIN SULFATE, 15 UNITS |
J9043 |
INJECTION, CABAZITAXEL, 1 MG |
J9045 |
INJECTION, CARBOPLATIN, 50 MG |
J9050 |
INJECTION, CARMUSTINE, 100 MG |
J9052 |
INJECTION, CARMUSTINE (ACCORD), NOT THERAPEUTICALLY EQUIVALENT TO J9050, 100 MG |
J9060 |
INJECTION, CISPLATIN, POWDER OR S0LUTION, 10 MG |
J9064 |
INJECTION, CABAZITAXEL (SANDOZ), NOT THERAPEUTICALLY EQUIVALENT TO J9043, 1 MG |
J9071 |
INJECTION, CYCLOPHOSPHAMIDE, (AUROMEDICS), 5 MG |
J9072 |
INJECTION, CYCLOPHOSPHAMIDE (AVYXA), 5 MG |
J9073 |
INJECTION, CYCLOPHOSPHAMIDE (DR. REDDY S), 5 MG |
J9074 |
INJECTION, CYCLOPHOSPHAMIDE (SANDOZ), 5 MG |
J9075 |
INJECTION, CYCLOPHOSPHAMIDE, NOT OTHERWISE SPECIFIED, 5MG |
J9076 |
INJECTION, CYCLOPHOSPHAMIDE (BAXTER), 5 MG |
J9100 |
INJECTION, CYTARABINE, 100 MG. |
J9130 |
DACARBAZINE, 100 MG |
J9150 |
INJECTION, DAUNORUBICIN, 10 MG |
J9153 |
INJECTION, LIPOSOMAL, 1 MG DAUNORUBICIN AND 2.27 MG CYTARABINE |
J9155 |
INJECTION, DEGARELIX, 1 MG |
J9171 |
INJECTION, DOCETAXEL, 1 MG |
J9172 |
INJECTION, DOCETAXEL (DOCIVYX), 1 MG |
J9174 |
INJECTION, DOCETAXEL (BEIZRAY), 1 MG |
J9176 |
INJECTION, ELOTUZUMAB, 1 MG |
J9179 |
INJECTION, ERIBULIN MESYLATE, 0.1 MG |
J9181 |
INJECTION, ETOPOSIDE, 10 MG |
J9184 |
INJECTION, GEMCITABINE HYDROCHLORIDE (AVYXA), 200 MG |
J9185 |
INJECTION, FLUDARABINE PHOSPHATE, 50 MG |
J9190 |
FLUOROURACIL, 500 MG |
J9196 |
INJECTION, GEMCITABINE HYDROCHLORIDE (ACCORD), NOT THERAPEUTICALLY EQUIVALENT TO J9201, 200 MG |
J9198 |
INJECTION, GEMCITABINE HYDROCHLORIDE, (INFUGEM), 100 MG |
J9201 |
INJECTION, GEMCITABINE HYDROCHLORIDE, NOT OTHERWISE SPECIFIED, 200 MG |
J9202 |
GOSERELIN ACETATE IMPLANT, PER 3.6 MG |
J9203 |
INJECTION, GEMTUZUMAB OZOGAMICIN, 0.1 MG |
J9204 |
INJECTION, MOGAMULIZUMAB-KPKC, 1 MG |
J9206 |
INJECTION, IRINOTECAN, 20 MG |
J9207 |
INJECTION, IXABEPILONE, 1 MG |
J9208 |
INJECTION, IFOSFAMIDE, 1 GM |
J9211 |
INJECTION, IDARUBICIN HYDROCHLORIDE, 5 MG |
J9214 |
INJECTION, INTERFERON, ALFA-2B, RECOMBINANT, 1 MILLION UNITS |
J9216 |
INTERFERON, GAMMA 1-B, 3 MILLION UNITS |
J9223 |
INJECTION, LURBINECTEDIN, 0.1 MG |
J9245 |
INJECTION, MELPHALAN HYDROCHLORIDE, NOT OTHERWISE SPECIFIED, 50 MG |
J9249 |
INJECTION, MELPHALAN (APOTEX), 1 MG |
J9263 |
INJECTION, OXALIPLATIN, 0.5 MG |
J9264 |
INJECTION, PACLITAXEL PROTEIN-BOUND PARTICLES, 1 MG |
J9267 |
INJECTION, PACLITAXEL, 1 MG |
J9280 |
INJECTION, MITOMYCIN, 5 MG |
J9281 |
MITOMYCIN PYELOCALYCEAL INSTILLATION, 1 MG |
J9292 |
INJECTION, PEMETREXED DIPOTASSIUM, 10 MG |
J9294 |
INJECTION, PEMETREXED (HOSPIRA), NOT THERAPEUTICALLY EQUIVALENT TO J9305, 10 MG |
J9295 |
INJECTION, NECITUMUMAB, 1 MG |
J9296 |
INJECTION, PEMETREXED (ACCORD), NOT THERAPEUTICALLY EQUIVALENT TO J9305, 10 MG |
J9297 |
INJECTION, PEMETREXED (SANDOZ), NOT THERAPEUTICALLY EQUIVALENT TO J9305, 10 MG |
J9302 |
INJECTION, OFATUMUMAB, 10 MG |
J9304 |
INJECTION, PEMETREXED (PEMFEXY), 10 MG |
J9305 |
INJECTION, PEMETREXED, NOT OTHERWISE SPECIFIED, 10 MG |
J9314 |
INJECTION, PEMETREXED (TEVA), NOT THERAPEUTICALLY EQUIVALENT TO J9305, 10 MG |
J9318 |
INJECTION, ROMIDEPSIN, NON-LYOPHILIZED, 0.1 MG |
J9319 |
INJECTION, ROMIDEPSIN, LYOPHILIZED, 0.1 MG |
J9322 |
INJECTION, PEMETREXED (BLUEPOINT), NOT THERAPEUTICALLY EQUIVALENT TO J9305, 10 MG |
J9323 |
INJECTION, PEMETREXED DITROMETHAMINE, 10 MG |
J9324 |
INJECTION, PEMETREXED (PEMRYDI RTU), 10 MG |
J9325 |
INJECTION, TALIMOGENE LAHERPAREPVEC, PER 1 MILLION PLAQUE FORMING UNITS |
J9328 |
INJECTION, TEMOZOLOMIDE, 1 MG |
J9341 |
INJECTION, THIOTEPA (TEPYLUTE), 1 MG |
J9342 |
INJECTION, THIOTEPA, NOT OTHERWISE SPECIFIED, 1 MG |
J9348 |
INJECTION, NAXITAMAB-GQGK, 1 MG |
J9351 |
INJECTION, TOPOTECAN, 0.1 MG |
J9352 |
INJECTION, TRABECTEDIN, 0.1 MG |
J9357 |
INJECTION, VALRUBICIN, INTRAVESICAL, 200 MG |
J9360 |
VINBLASTINE SULFATE, 1 MG |
J9370 |
VINCRISTINE SULFATE, 1 MG |
J9390 |
VINORELBINE TARTRATE, PER 10 MG |
J9400 |
INJECTION, ZIV-AFLIBERCEPT, 1 MG |
J9600 |
INJECTION, PORFIMER SODIUM, 75 MG |
Q0138 |
INJECTION, FERUMOXYTOL, FOR TREATMENT OF IRON DEFICIENCY ANEMIA, 1 MG (NON-ESRD USE) |
Q2050 |
INJECTION, DOXORUBICIN HYDROCHLORIDE, LIPOSOMAL, NOT OTHERWISE SPECIFIED, 10MG |
Q5106 |
INJECTION, EPOETIN ALFA-EPBX, BIOSIMILAR, (RETACRIT) (FOR NON-ESRD USE), 1000 UNITS |
Quick Info
Never miss out on what matters. Subscribe to our emails and stay informed.